Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Stroke|August 1, 2013
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialDavid Preiss, Thomas D Giles, Laine E Thomas, et al.
Diabetes Care|September 28, 2002
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetesGiancarlo Viberti, Steven E Kahn, Douglas A Greene, et al.
American Journal of Hypertension|May 16, 2009
Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African AmericansKimberly J Schmitz, Halcyon G Skinner, Leonelo E Bautista, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
Lancet (London, England)|December 24, 2013
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysisThomas Yates, Steven M Haffner, Phillip J Schulte, et al.
Metabolism: Clinical and Experimental|February 25, 2014
Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: results from NAVIGATORKim M Huffman, Jie-Lena Sun, Laine Thomas, et al.
BMJ Open|December 4, 2012
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trialDavid Preiss, Laine E Thomas, Jie-Lena Sun, et al.
Obesity (Silver Spring, Md.)|May 23, 2009
Genome-wide association study and follow-up analysis of adiposity traits in Hispanic Americans: the IRAS Family StudyJill M Norris, Carl D Langefeld, Matthew E Talbert, et al.
Genetic Epidemiology|October 4, 2012
Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectinS Sandy An, Nicholette D Palmer, Anthony J G Hanley, et al.
Pageof 20